Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
24.22
-0.20 (-0.82%)
Nov 21, 2024, 4:00 PM EST - Market closed
Denali Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
| Net Income | -427.49 | -145.22 | -325.99 | -290.58 | 71.14 | -197.61 | Upgrade
|
| Depreciation & Amortization | 0.65 | 8.83 | 10.38 | 8.59 | 8.53 | 7.99 | Upgrade
|
| Loss (Gain) From Sale of Assets | -14.54 | - | - | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 7.9 | 7.9 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -41.2 | -43.95 | -1.64 | 8.75 | 0.06 | -5.02 | Upgrade
|
| Stock-Based Compensation | 103.79 | 108.1 | 99.85 | 85.25 | 50.35 | 38.38 | Upgrade
|
| Other Operating Activities | -3.98 | -3.72 | -3.29 | -2.98 | -2.32 | 1.77 | Upgrade
|
| Change in Accounts Payable | -1.93 | 2.43 | 2.27 | 3.71 | -1.62 | 1.03 | Upgrade
|
| Change in Unearned Revenue | - | -290.53 | -34.46 | -15.66 | 278.17 | -6.29 | Upgrade
|
| Change in Other Net Operating Assets | 14.16 | -1.83 | 8.16 | -8.46 | 11.86 | 8.18 | Upgrade
|
| Operating Cash Flow | -362.64 | -357.99 | -244.72 | -211.39 | 416.15 | -151.58 | Upgrade
|
| Capital Expenditures | -13.06 | -12.94 | -17.83 | -8.5 | -3.1 | -17.92 | Upgrade
|
| Investment in Securities | -174.86 | 262.25 | -123.55 | -13.13 | -620.11 | 165.63 | Upgrade
|
| Investing Cash Flow | -187.92 | 249.31 | -141.39 | -21.63 | -623.21 | 147.71 | Upgrade
|
| Net Debt Issued (Repaid) | -24.02 | - | - | - | - | - | Upgrade
|
| Issuance of Common Stock | 517.67 | 17.82 | 310.67 | 19.35 | 634.75 | 6.19 | Upgrade
|
| Other Financing Activities | -0.48 | - | - | - | - | - | Upgrade
|
| Financing Cash Flow | 493.18 | 17.82 | 310.67 | 19.35 | 634.75 | 6.19 | Upgrade
|
| Net Cash Flow | -57.38 | -90.86 | -75.43 | -213.67 | 427.7 | 2.33 | Upgrade
|
| Free Cash Flow | -375.69 | -370.93 | -262.55 | -219.89 | 413.06 | -169.5 | Upgrade
|
| Free Cash Flow Margin | - | -112.22% | -242.06% | -451.88% | 123.06% | -635.34% | Upgrade
|
| Free Cash Flow Per Share | -2.40 | -2.70 | -2.09 | -1.81 | 3.67 | -1.77 | Upgrade
|
| Cash Income Tax Paid | - | 0 | 0.05 | 0.21 | - | - | Upgrade
|
| Levered Free Cash Flow | -212.81 | -298.35 | -141.03 | 200.41 | 109.03 | -94.03 | Upgrade
|
| Unlevered Free Cash Flow | -212.74 | -298.35 | -141.03 | 200.41 | 109.03 | -94.03 | Upgrade
|
| Change in Net Working Capital | -16.19 | 279.4 | 20.47 | -299.91 | -14.05 | -10.76 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.